NO20050337L - Oral doseringsform omfattende en flytende formulering av et aktivt middel samt en kontrollert frigivning derav ved hjelp av osmotisk ekspanderbart preparat - Google Patents

Oral doseringsform omfattende en flytende formulering av et aktivt middel samt en kontrollert frigivning derav ved hjelp av osmotisk ekspanderbart preparat

Info

Publication number
NO20050337L
NO20050337L NO20050337A NO20050337A NO20050337L NO 20050337 L NO20050337 L NO 20050337L NO 20050337 A NO20050337 A NO 20050337A NO 20050337 A NO20050337 A NO 20050337A NO 20050337 L NO20050337 L NO 20050337L
Authority
NO
Norway
Prior art keywords
dosage form
liquid
liquid formulation
formulation
controlled release
Prior art date
Application number
NO20050337A
Other languages
English (en)
Norwegian (no)
Inventor
Patrick S L Wong
Liang-Chang Dong
Keru Shafi
Alicia Yum
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO20050337L publication Critical patent/NO20050337L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
NO20050337A 2002-06-28 2005-01-21 Oral doseringsform omfattende en flytende formulering av et aktivt middel samt en kontrollert frigivning derav ved hjelp av osmotisk ekspanderbart preparat NO20050337L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39277402P 2002-06-28 2002-06-28
PCT/US2003/020422 WO2004002448A1 (en) 2002-06-28 2003-06-27 Oral dosage from comprising a liquid active agent formulation andcontrolling release thereof by an expandable osmotic composition

Publications (1)

Publication Number Publication Date
NO20050337L true NO20050337L (no) 2005-01-21

Family

ID=30000933

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050337A NO20050337L (no) 2002-06-28 2005-01-21 Oral doseringsform omfattende en flytende formulering av et aktivt middel samt en kontrollert frigivning derav ved hjelp av osmotisk ekspanderbart preparat

Country Status (15)

Country Link
US (1) US20040058000A1 (de)
EP (1) EP1521570A1 (de)
JP (1) JP2005533084A (de)
KR (1) KR20050071376A (de)
CN (1) CN1678291A (de)
AR (1) AR040306A1 (de)
AU (1) AU2003245738A1 (de)
CA (1) CA2490412A1 (de)
IL (1) IL166023A0 (de)
MX (1) MXPA05000206A (de)
NO (1) NO20050337L (de)
NZ (1) NZ537492A (de)
TW (1) TW200531708A (de)
WO (1) WO2004002448A1 (de)
ZA (1) ZA200500834B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200518790A (en) * 2003-07-31 2005-06-16 Alza Corp Osmotic engine & dosage form for controlled release of a liquid active agent formulation
WO2005030165A1 (en) * 2003-09-26 2005-04-07 Alza Corporation Dosage form for controlled release of an active agent formulation
AU2004314693B2 (en) 2003-09-26 2011-04-07 Alza Corporation Drug coating providing high drug loading and methods for providing the same
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US20070014847A1 (en) * 2005-07-05 2007-01-18 Ahmed Salah U Coated capsules and methods of making and using the same
FR2934805A1 (fr) 2008-08-07 2010-02-12 Inergy Automotive Systems Res Procede pour fixer un accessoire dans un corps creux en matiere plastique lors de son moulage.
US20220409490A1 (en) * 2020-03-02 2022-12-29 Craft Health Pte Ltd Method of manufacturing oral dosage forms for extended drug release
CN115490316B (zh) * 2022-01-24 2023-09-12 成都理工大学 一种可再利用的地下水营养物质缓释胶囊体

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US36472A (en) * 1862-09-16 Cttlvebt
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US5391381A (en) * 1987-06-25 1995-02-21 Alza Corporation Dispenser capable of delivering plurality of drug units
US5034229A (en) * 1988-12-13 1991-07-23 Alza Corporation Dispenser for increasing feed conversion of hog
US5223265A (en) * 1992-01-10 1993-06-29 Alza Corporation Osmotic device with delayed activation of drug delivery
EP0804174A4 (de) * 1993-07-21 1998-09-09 Univ Kentucky Res Found Mehrkammerhartkapseln mit kontrollierten abgabeeigenschaften
GB9326267D0 (en) * 1993-12-23 1994-02-23 Scherer Corp R P Expulsion of material
US5614578A (en) * 1994-10-28 1997-03-25 Alza Corporation Injection-molded dosage form
AU5175998A (en) * 1996-11-15 1998-06-03 Alza Corporation Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
US6245357B1 (en) * 1998-03-06 2001-06-12 Alza Corporation Extended release dosage form
US6551613B1 (en) * 1998-09-08 2003-04-22 Alza Corporation Dosage form comprising therapeutic formulation
US6174547B1 (en) * 1999-07-14 2001-01-16 Alza Corporation Dosage form comprising liquid formulation
JP2002532406A (ja) * 1998-12-17 2002-10-02 アルザ・コーポレーション 複合コーティングによる液体充填ゼラチンカプセルの放出制御システムへの変換
CA2355860C (en) * 1998-12-23 2010-03-30 Alza Corporation Dosage forms comprising porous particles
JP2003516345A (ja) * 1999-12-09 2003-05-13 アルザ・コーポレーション 抗ウイルス剤
US20030232078A1 (en) * 2001-12-19 2003-12-18 Dong Liang C. Formulation & dosage form for the controlled delivery of therapeutic agents
CN1606432A (zh) * 2001-12-19 2005-04-13 阿尔扎公司 用于增加亲水性大分子的口服生物利用度的制剂和剂型

Also Published As

Publication number Publication date
WO2004002448A1 (en) 2004-01-08
AU2003245738A1 (en) 2004-01-19
TW200531708A (en) 2005-10-01
CN1678291A (zh) 2005-10-05
JP2005533084A (ja) 2005-11-04
NZ537492A (en) 2007-10-26
IL166023A0 (en) 2006-01-15
US20040058000A1 (en) 2004-03-25
EP1521570A1 (de) 2005-04-13
MXPA05000206A (es) 2005-12-05
ZA200500834B (en) 2006-04-26
CA2490412A1 (en) 2004-01-08
AR040306A1 (es) 2005-03-23
KR20050071376A (ko) 2005-07-07

Similar Documents

Publication Publication Date Title
NO20050337L (no) Oral doseringsform omfattende en flytende formulering av et aktivt middel samt en kontrollert frigivning derav ved hjelp av osmotisk ekspanderbart preparat
CN107847398B (zh) 控制释放的药物剂型
BRPI0414941A (pt) dispositivo de distribuição de agente ativo acionado osmoticamente proporcionando um perfil de liberação ascendente
WO2005065319A3 (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
NO20061859L (no) OROS Push Stick for kontrollert tilforsel av aktive midler
WO2006123357A3 (en) Oral controlled release composition containing levetiracetam
WO2006011159A3 (en) Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability
HRP20040323C1 (hr) Oralni oblici davanja propiverina ili njegovih farmaceutski prihvatljivih soli s produljenim oslobađanjem djelotvone supstance
NO20092998L (no) Flytende formuleringer, som danner dermal film, for frigjoring av legemidler til huden
ITMI951223A1 (it) Forma farmaceutica solida ad uso orale
FR2889811B1 (fr) Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique.
NO20055631L (no) Doseringsform inneholdende pantoprazol som aktiv ingrediens
NO20083027L (no) Kontrollert frigivelses-fastformpreparat
CO5640120A2 (es) Formulacion y metodods para el tratamiento de trombocitemia
WO2005016306A3 (en) Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
WO2005079750A3 (en) Films for use as dosage forms
MX2010007281A (es) Composiciones farmaceuticas de amlodipina y valsartan.
WO2006108692A3 (en) Dosage form for oral administration of a vitamin
JP2006525315A5 (de)
WO2005007137A3 (de) Ambroxolhaltige tabletten
CL2004000697A1 (es) Dispositivo de administracion osmotica que comprende: un reservorio, una composicion osmotica, la formulacion de la droga, y una membrana precargada que comprende un material semipermeable y un material liquido de relleno seleccionado de un polietile
CO5580741A2 (es) Composicion farmaceutica que comprende un agonista de receptor de 5ht1
CN109152773A (zh) 用于治疗无烟烟草成瘾的含有大麻二酚和尼古丁的药物制剂
WO2004034962A3 (en) Selective cytokine inhibitory drugs for treating myelodysplastic syndrome
WO2006111981A3 (en) Film coating compositions and methods providing moisture barrier

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application